CME Group Inc. Reports Strong Second-Quarter 2016 Financial Results

Go back to CME Group Inc. Reports Strong Second-Quarter 2016 Financial Results

UBS Reiterates Buy on CME Group (CME) Following 2Q

July 29, 2016 8:48 AM EDT

UBS reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target to $114.00 (from $104.00), following the company's 2Q earnings report. UBS raised FY16 EPS estimates to $4.42 from $4.32, and FY17 to $4.95 from $4.80.

Analyst Alex Kramm commented, "CME shares underperformed following its 2Q release,... More

CME Group (CME) Tops Q2 EPS by 5c

July 28, 2016 7:19 AM EDT

CME Group (NASDAQ: CME) reported Q2 EPS of $1.14, $0.05 better than the analyst estimate of $1.09. Revenue for the quarter came in at $906 million versus the consensus estimate of $897.84 million.

For earnings history and earnings-related data on CME Group (CME) click here.

... More